What's in Repros Therapeutics Inc.'s pipeline?

Repros Therapeutics Inc. has 16 drugs in our index: 2 marketed, 0 filed, 1 in Phase 3, 1 in Phase 2, 11 in Phase 1.

Which companies overlap with Repros Therapeutics Inc.'s portfolio?

Top competitors by shared drug class: Abbott, Acerus Pharmaceuticals Corporation, Acrux DDS Pty Ltd, Alliance for Clinical Trials in Oncology, Bayer.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/repros-therapeutics-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Repros Therapeutics Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Repros Therapeutics Inc. pipeline: 2 marketed, 0 filed, 1 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 1 Phase 3 1 Phase 2 11 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Placebo Capsules	Placebo Capsules	marketed
AndroGel 1.62%	AndroGel 1.62%	marketed	Androgen replacement therapy	Androgen receptor	Endocrinology
Androxal	Androxal	phase 3			Other

Therapeutic area mix

Other · 3
Endocrinology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Abbott · 1 shared drug class
Acerus Pharmaceuticals Corporation · 1 shared drug class
Acrux DDS Pty Ltd · 1 shared drug class
Alliance for Clinical Trials in Oncology · 1 shared drug class
Bayer · 1 shared drug class
Beersheva Mental Health Center · 1 shared drug class
Clarus Therapeutics, Inc. · 1 shared drug class
Imperial College Healthcare NHS Trust · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Repros Therapeutics Inc.:

Cite this brief

Drug Landscape (2026). Repros Therapeutics Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/repros-therapeutics-inc. Accessed 2026-05-18.